Average Co-Inventor Count = 5.89
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. International Aids Vaccine Initiative (24 from 68 patents)
2. The Scripps Research Institute (19 from 1,187 patents)
3. Theraclone Sciences, Inc. (14 from 28 patents)
4. Cornell University (3 from 1,361 patents)
5. Other (1 from 832,843 patents)
6. The United States of America, As Represented by the Secretary, Department of Health and Human Services (1 from 3,539 patents)
7. Theraclone Science, Int. (0 patent)
25 patents:
1. 12410243 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
2. 12312396 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
3. RE50268 - Broadly neutralizing antibody and uses thereof
4. 12018067 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
5. 11845789 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
6. 11584789 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
7. 11319362 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
8. RE49037 - Broadly neutralizing antibody and uses thereof
9. 10894080 - Transgenic VERO-CD4/CCR5 cell line
10. 10865234 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
11. 10836811 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
12. 10407493 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
13. 10279027 - Transgenic Vero-CD4/CCR5 cell line
14. 10239934 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
15. 10093720 - Broadly neutralizing antibody and uses thereof